Verastem clinical trials we track

Check company identity source

Phase 3 1 trial

TrialDrugs studiedStatusPrimary completion
A Study of Avutometinib (VS-6766) + Defactinib (VS-6063) in Recurrent Low-Grade Serous Ovarian CancerNCT06072781Anastrozole, Defactinib, Letrozole, Paclitaxel and 2 moreRecruiting2028-10-15Estimated

Phase 2 7 trials

Phase 1 / 2 1 trial

Drugs in these trials

Names as written in the registry records.

Latest recorded trial changes

Filters
Clear filters

· 3 fields changed

Participant count type changed

Before: Estimated. After: Actual.

Enrollment · participant count changed

Before: 15 participants (planned). After: 16 participants (actual).

Recruitment status changed

Before: Recruiting. After: Active not recruiting.

Check registry source